Dr. James Hagop Tabibian, MD

Dr. Tabibian practices at Adventist Health Physicians Network in Glendale, California.

Dr. Tabibian's NPI, 1831356732, was assigned on May 19, 2008. Dr. Tabibian graduated from David Geffen School of Medicine at UCLA in 2008. Dr. Tabibian's California license number on file is A142008.

Dr. Tabibian's primary practice is Adventist Health Physicians Network, at 1505 Wilson Ter, Glendale, CA 91206 in Los Angeles County. The practice phone is (818) 243-8431.

Dr. Tabibian's primary practice is Adventist Health Physicians Network in Glendale, California. Dr. Tabibian is also affiliated with Adventist Health Glendale. The medical group on file is Adventist Health Physicians Network. Dmand AI also links Dr. Tabibian to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tabibian practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Tabibian's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Tabibian is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Tabibian's licenses on file in 3 states: California, Pennsylvania and Minnesota.

CMS data shows 1,110 Medicare services from Dr. Tabibian across 22 procedure codes in 2024, for 337 Medicare patients. Medicare paid $106,438 for them.

CMS counts 337 Medicare patients who saw Dr. Tabibian in 2024. The largest group is 65 to 74, with 144 patients. 75% of them have arthritis, and 75% have high blood pressure. 76% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tabibian's median patient age at 53, with 57% women.

In 2024, Dr. Tabibian wrote 293 Medicare Part D claims for 133 patients. 79% of them were for generic drugs. CMS names the drug for 220 of them, across 8 drugs with 11 or more claims each, at $58,610 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Tabibian for performance year 2024, reported through an alternative payment model (APM). Dr. Tabibian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tabibian as offering telehealth. CMS counts 441 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Tabibian, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 109 papers to Dr. Tabibian, published from 2015 to 2025. 2021 was the busiest year, with 19. The most frequent topics are Cholangitis, Sclerosing, Gastroenterology and Inflammatory Bowel Diseases. Dr. Tabibian has published most often in World J Gastrointest Endosc. Dr. Tabibian's most frequent co-authors are Brian M. Fung, MD, Simcha Weissman, DO and Mohit Girotra, MBBS, MD.

CMS Open Payments shows 180 general payments to Dr. Tabibian from 24 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 46% of the total. Olympus Corporation of the Americas paid the most, $18,407.

Dr. Tabibian graduated from David Geffen School of Medicine at UCLA in 2008.

Dr. Tabibian is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.